Smith Shellnut Wilson »

Corcept Therapeutics Incorporated shares owned by Smith Shellnut Wilson

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Smith Shellnut Wilson from 13F filings

Historical chart of Smith Shellnut Wilson investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Smith Shellnut Wilson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Smith Shellnut Wilson

Quarter filed Position value Share count Share price at filing
2025-09-30 $401k 4.8k 83.11
2025-06-30 $354k 4.8k 73.40
2025-03-31 $550k 4.8k 114.22
2024-12-31 $243k 4.8k 50.39
2024-09-30 $223k 4.8k 46.28

More positions owned by Smith Shellnut Wilson

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Oracle Corporation (ORCL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Us Aggbd Et (AGG)
Proshares Tr S&p 500 Dv Arist (NOBL)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Fidelity Covington Trust Msci Info Tech I (FTEC)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p Scp Etf (IJR)

View all positions for Smith Shellnut Wilson

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated